NFKB1 and neoplasm: Furthermore, loss of RASSF8 in ESCC cells may promote lymphatic endothelium migration and capillary-like tube formation, and in vivo tumor lymphangiogenesis and lymphatic metastasis, via VEGF-C upregulation under NF-κB transcriptional control.